Elecoglipron-matched placebo
Sponsors
AstraZeneca
Conditions
Type 2 Diabetes Mellitus
Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
RecruitingNCT07662044
Start: 2026-07-06End: 2028-07-14Target: 800Updated: 2026-08-31
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
RecruitingNCT07662109
Start: 2026-07-06End: 2028-07-05Target: 2000Updated: 2026-08-31